Topical Cyclosporine and Disease Progression

• Status: Completed
• Trial end date: 2008-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effect Restasis has in regards to disease progression.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Innovative Medical
• Treatments: Cyclosporine; Cyclosporins

Criteria

Inclusion Criteria:

• Mild to Moderate dry eye symptoms

Exclusion Criteria:

• Current use of Restasis